SALIX PHARMACEUTICALS LTD Research and Development Expense
SALIX PHARMACEUTICALS LTD reported Research and Development Expense of $170.29 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD research and development expense for the quarter ending 2014-12-31 was $66.81M, a 148.38% increase year-over-year.
- SALIX PHARMACEUTICALS LTD research and development expense for the quarter ending 2014-09-30 was $50.84M, a 74.22% increase year-over-year.
- SALIX PHARMACEUTICALS LTD research and development expense for the quarter ending 2014-06-30 was $25.58M, a 27.15% decline year-over-year.
- SALIX PHARMACEUTICALS LTD research and development expense for the quarter ending 2014-03-31 was $41.22M, a 90.80% increase year-over-year.
- SALIX PHARMACEUTICALS LTD research and development expense for fiscal 2014 was $170.29M, a 50.98% increase from fiscal 2013.
- SALIX PHARMACEUTICALS LTD research and development expense for fiscal 2013 was $112.79M, a 32.75% increase from fiscal 2012.
- SALIX PHARMACEUTICALS LTD research and development expense for fiscal 2012 was $84.96M, a 18.23% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD research and development expense for fiscal 2011 was $71.86M, a 2.02% decline from fiscal 2010.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $66.81M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $103.49M derived: sum of 2 quarters · filed 2015-03-02 | $129.07M derived: sum of 3 quarters · filed 2015-03-02 | $170.29M 10-K · filed 2015-03-02 | ||||
| 2014-09-30 | $50.84M 10-Q · filed 2014-11-07 | $62.25M derived: sum of 2 quarters · filed 2015-03-02 | $103.48M 10-Q/A · filed 2015-03-02 | $142.83M 10-Q · filed 2014-11-07 | $130.38M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2014-06-30 | $25.58M 10-Q/A · filed 2015-03-02 | $39.23M 10-Q · filed 2014-08-08 | $66.80M 10-Q/A · filed 2015-03-02 | $91.99M 10-Q · filed 2014-08-08 | $93.70M derived: sum of 3 quarters · filed 2015-03-02 | $122.88M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2014-03-31 | $41.22M 10-Q/A · filed 2015-03-02 | $52.76M 10-Q · filed 2014-05-09 | $68.12M derived: sum of 2 quarters · filed 2015-03-02 | $97.30M derived: sum of 3 quarters · filed 2015-03-02 | $132.41M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-12-31 | $26.90M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $56.08M derived: sum of 2 quarters · filed 2015-03-02 | $91.19M derived: sum of 3 quarters · filed 2015-03-02 | $112.79M 10-K · filed 2015-03-02 | $149.97M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $29.18M 10-Q/A · filed 2015-03-02 | $38.20M 10-Q · filed 2013-11-08 | $64.29M derived: sum of 2 quarters · filed 2015-03-02 | $85.89M 10-Q/A · filed 2015-03-02 | $113.73M 10-Q · filed 2013-11-08 | $84.18M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $35.11M 10-Q/A · filed 2015-03-02 | $45.22M 10-Q · filed 2013-08-09 | $56.71M 10-Q/A · filed 2015-03-02 | $75.54M 10-Q · filed 2013-08-09 | $55.00M derived: sum of 3 quarters · filed 2015-03-02 | $87.82M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $21.61M 10-Q/A · filed 2015-03-02 | $30.32M 10-Q · filed 2013-05-10 | $19.89M derived: sum of 2 quarters · filed 2015-03-02 | $52.71M derived: sum of 3 quarters · filed 2015-03-02 | $79.87M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $31.11M derived: sum of 2 quarters · filed 2015-03-02 | $58.26M derived: sum of 3 quarters · filed 2015-03-02 | $84.96M 10-K · filed 2015-03-02 | $123.23M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $32.82M 10-Q · filed 2013-11-08 | $59.98M derived: sum of 2 quarters · filed 2013-11-08 | $86.68M 10-Q · filed 2013-11-08 | $73.24M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-06-30 | $27.16M 10-Q · filed 2013-08-09 | $53.86M 10-Q · filed 2013-08-09 | $40.42M derived: sum of 3 quarters · filed 2015-03-02 | $65.24M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-03-31 | $26.70M 10-Q · filed 2013-05-10 | $13.27M derived: sum of 2 quarters · filed 2015-03-02 | $38.08M derived: sum of 3 quarters · filed 2015-03-02 | $67.56M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2011-12-31 | -$13.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $11.38M derived: sum of 2 quarters · filed 2015-03-02 | $40.86M derived: sum of 3 quarters · filed 2015-03-02 | $71.86M 10-K · filed 2015-03-02 | $104.35M 10-K · filed 2012-02-28 | |||
| 2011-09-30 | $24.81M 10-Q · filed 2012-11-08 | $54.29M derived: sum of 2 quarters · filed 2012-11-08 | $85.29M 10-Q · filed 2012-11-08 | $97.13M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $29.48M 10-Q · filed 2012-08-09 | $60.48M 10-Q · filed 2012-08-09 | $72.32M derived: sum of 3 quarters · filed 2013-03-01 | $92.05M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $31.00M 10-Q · filed 2012-05-08 | $42.84M derived: sum of 2 quarters · filed 2013-03-01 | $62.57M derived: sum of 3 quarters · filed 2013-03-01 | $85.59M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $11.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $31.57M derived: sum of 2 quarters · filed 2013-03-01 | $54.59M derived: sum of 3 quarters · filed 2013-03-01 | $73.35M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $19.73M 10-Q · filed 2011-11-09 | $42.75M derived: sum of 2 quarters · filed 2011-11-09 | $61.51M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $23.02M 10-Q · filed 2011-08-09 | $41.78M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | $18.76M 10-Q · filed 2011-05-10 | |||||||
| 2009-12-31 | $89.47M 10-K · filed 2012-02-28 |